GF Fund Management’s AC Immune ACIU Stock Holding History
Bought
Maintained
Sold
Other funds holding ACIU
SBCM
GF Fund Management's ACIU Position: Q3 2026 in Review
GF Fund Management increased its AC Immune (ACIU) stake by 8.9% in Q3 2026, buying an estimated $470 and bringing the position to 2,269 shares worth $5.94K. The position accounts for ﹤0.01% of the portfolio, ranked #568.
GF Fund Management first reported a position in ACIU in Q4 2024 and has held it in 8 quarters since. The position peaked at $6.24K in Q3 2025. 9 funds tracked by Wall St. Rank hold ACIU as of Q3 2026.
- GF Fund Management held 2,269 shares of AC Immune worth $5.94K as of Q3 2026.
- GF Fund Management bought 185 AC Immune shares in Q3 2026, an estimated $470.
- AC Immune made up ﹤0.01% of GF Fund Management's portfolio in Q3 2026, its #568 holding.
- GF Fund Management first reported a position in AC Immune in Q4 2024 and has held it in 8 quarters since.
- GF Fund Management's AC Immune position peaked at $6.24K in Q3 2025.
- 9 funds tracked by Wall St. Rank held AC Immune as of Q3 2026.
Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.